CEO, Huma.ai
[LinkedIn Profile](http://www.linkedin.com/in/susan-shiff)
Executive Summary
Susan Shiff, PhD, MBA, is the Chief Executive Officer of Huma.ai, a health technology company driving innovation in artificial intelligence (AI) and natural language processing (NLP) for the healthcare and life sciences markets. With over 20 years of executive leadership across major pharmaceutical and healthcare organizations, Dr. Shiff brings substantial experience in real-world evidence generation, health economics, access strategy, and the commercialization of healthcare technology solutions.
Professional Background
- Current Role:
- CEO, Huma.ai
- Appointed President, CEO & Director in 2024
- Responsible for leading strategic direction, innovation, and growth
- Key Achievements at Huma.ai:
- Instrumental in securing recent investments, including a new equity funding round of $2,500,000 (October 2024).
- Primary driver for innovation in leveraging AI and NLP to empower efficient, secure insight generation in healthcare, aiming to improve the pace and quality of medical decision-making and support scientific breakthroughs.
- Leads an executive team comprised of senior leaders in finance and technology, with Bob Cotton as CFO and Eliot Levitt as CTO.
- Active engagement in thought leadership, regularly sharing insights about the application and value of AI in healthcare.
- Relevant Previous Experience:
- President/CEO, Ontada
- Led a US-based health technology company focused on real-world data, technology, and educational solutions for oncology.
- Senior Vice President, Merck & Co.
- Headed the Center for Observational and Real-World Evidence (CORE), overseeing global value evidence generation, access strategy, and patient outcomes optimization for Merck’s portfolio.
- Global Vice President, Health Economics Research & Evidence-Based Medicine, Teva Pharmaceuticals
- Executive Leadership, Pfizer
- Vice President roles in outcomes research, epidemiology, health economics, and market access/pricing.
- Leader of Global Risk Management and US HEOR, Roche
- U.S. Centers for Disease Control and Prevention (CDC), Service of Four Years
Governance & Board Memberships
- Current Board Positions:
- Board of Directors, Huma.ai (CEO & Director)
- Board Member, Synthace Limited
- Trustee, New Jersey Symphony Orchestra
- Advisory Roles:
- Institute for Clinical and Economic Review (ICER): Advisory Board and Methods Subcommittee
- Health Technology Assessment International (HTAi): Policy Advisory Board
- Innovation and Value Initiative (IVI): Panel of Health Advisors
Industry Recognition
- FiercePharma – Top 15 Women in Biopharma (2016)
- Frequently cited as a thought leader in health economics, real-world evidence, and AI in healthcare.
Education
- PhD – University of California, Los Angeles (UCLA)
- MBA – Cornell University
Strategic Insights
Susan Shiff’s tenure as CEO at Huma.ai corresponds with a period of expansion and investment, bolstered by her extensive background in evidence generation, value demonstration, and health technology commercialization. Her leadership directly supports Huma.ai’s mission to deliver data-driven, actionable insights to healthcare and life sciences decision-makers through intelligent, secure platforms. Dr. Shiff’s connections across large pharma, technology providers, and industry consortia position her as a key access point for engagement with both biopharma and health technology executives. Huma.ai’s leadership alignment under her stewardship is tightly focused on accelerating healthcare digital transformation and enabling real-world evidence utility via AI.
Professional Interests
- Artificial Intelligence in Healthcare
- Real-World Data & Evidence
- Health Economics & Market Access
- Data-Driven Decision Making
- Pharmaceutical Value Communication
- Healthcare Analytics Platforms
Organizational Structure and Board Network
Huma.ai’s executive and governance teams include highly experienced professionals in finance, technology, and venture capital. The board features influential leaders from healthcare investment, digital health, and medical device backgrounds, offering extended reach into innovative healthcare and technology ecosystems.
For additional professional details, refer to [Susan Shiff’s LinkedIn profile](http://www.linkedin.com/in/susan-shiff).
